Skip to content
Ep 78 · 54:56

Full transcript

Machine transcribed. Not yet read against the audio.

← Back to the episode
Research use only

Any compounds discussed may be intended for research purposes only. Nothing here is a protocol to follow — amounts, timing and cycle lengths are reported as the named speaker described them.

We are not doctors. Use at your own risk.

525 LINES
Download .txt
Skip the transcript
0:00Speaker 0Chronic migraine: 15 or more headache days a month, each lasting 4 hours or more, can make me feel like a spectator in my own life. Botox, onabotulinum
0:08Speaker 2toxin A, prevents headaches in adults with chronic migraine. It's not for those with 14 or fewer headache days a month. It's the number 1 prescribed branded chronic migraine preventive treatment. Prescription Botox is injected by your doctor. Effects of Botox may spread hours to weeks after injection, causing serious symptoms. Alert your doctor right away as difficulty swallowing, speaking, breathing, eye problems, or muscle weakness can be signs of a life threatening condition. Patients with these conditions before injection are at highest risk. Side effects may include allergic reactions, neck and injection site pain, fatigue, and headache. Allergic reactions can include rash, welts, asthma symptoms, and dizziness. Don't receive Botox if there's a skin infection. Tell your doctor your medical history, muscle or nerve conditions, including ALS Lou Gehrig's disease, myasthenia gravis or Lambert Eaton syndrome, and medications, including botulinum toxins, as these may increase the risk of serious side effects. Why wait? Ask your doctor, visit botoxchronicmigraine.com,
0:57Speaker 0or call one-eight hundred-44Botox
0:59Speaker 1to learn more. Propel Fitness Water with Gatorade Electrolytes,
1:03Speaker 10 Sugar, and Vitamins. Propel hydrates better than water to help you get the most out of your workout and get back to your best self. What propels you? Propel with Gatorade Electrolytes.
1:24Speaker 2Welcome back to the Pep Tide of the Week Podcast. I'm your host, JD Denham across the way, my buddy, my pal, my business partner, my friend,
1:33Speaker 2William Teahawks. What's up, dude? What's up, man? It's Friday. Happy Friday. It is Friday. The time is flying, and today is a special day.
1:42Speaker 2We have a good friend of ours. We like to call him rather, but a good friend of ours. He's been on the show numerous times,
1:50Speaker 2and we bring him on when we wanna get the lowdown of what's going on on the streets of Peptides.
1:55Speaker 2So you've seen him numerous times if you've been following our podcast in any form for the last year or so.
2:02Speaker 2Paul Bactiar, he is a keynote speaker at multiple peptide conferences. I like to call him the peptide Jedi.
2:09Speaker 4But welcome to the show, my brother. Thank you always, my brothers. I appreciate you both and always appreciate the work that you're doing. Thanks again for inviting me on. Always appreciate being here. Yeah, man. Paul just said, if the world's gonna end, that he's gonna come to us True story. For survival.
2:25Speaker 4Absolutely. When
2:26Speaker 4it all goes down, end of the world, where do you wanna be shoulder to shoulder? And I go, there's nobody better than these 2 gents right here.
2:33Speaker 2That's it, baby. As iron sharpens iron, they say. That's right. I love it. I love it. So really quickly, man, how's life? How have you been, man? We, we all are busy. We catch up from time to time, but, just how's life in general, man? How how are things? Things have been good, man. It's been a blessing to be busy. Recently,
2:51Speaker 4took on a role of president of telehealth operations for a large medical manufacturer.
2:57Speaker 4In addition to that, still doing all my training, my education. I'll be speaking
3:02Speaker 4at the cell surgical network conference down there in your guys' neck of the woods in Manhattan Beach,
3:08Speaker 4coming up next month. So excited for that. Talking on peptides, things that we all know and love.
3:13Speaker 2Yeah, it's funny, man. I was thinking, I was thinking as we were kind of getting ready for this, that
3:17Speaker 2we're just 3 dorks that like to talk about peptides and compounds.
3:21Speaker 2We could sit here for hours and talking about them for over and over again. It's like, it's cool that we get to sit down and now it's just recorded because these are the conversations we have at dinner. Yeah.
3:34Speaker 2It's really that simple. Like, this is the stuff we talk about when we're hanging out anyway. It's
3:39Speaker 3easy. And it's the way that we have learned, right? It's like by asking questions and talking to people who also know, right? Like people ask me all the time, like, how do I, what do I do in the gym? Right? And like,
3:50Speaker 3how do I get in shape? Like, okay. That's not really a question that you can ask somebody to answer. Right? But I guess 1 of part of that answer is like, go to the gym and watch
4:00Speaker 3people who are better than you. Yep. And
4:02Speaker 3ask them questions. You know what mean? Like just go watch what exercises they are doing. They're doing something right, obviously. So
4:10Speaker 3basically surround yourself with people who know better than you or
4:13Speaker 3know different than you.
4:15Speaker 3Ask questions instead of guessing and your knowledge and you'll just get better. Basically. That's great advice as I like Yeah,
4:24Speaker 2man. Well,
4:25Speaker 2cool man. Welcome to the show. It is always a pleasure to talk with you and,
4:31Speaker 2you know, we bring you on when we wanna hear kind of the lowdown of what's going on on the streets. The peptide industry is
4:38Speaker 2always a little shaky, always a little gray, always
4:41Speaker 2needing to bob and weave around certain things. And the last time us 3 got together was
4:47Speaker 2at the end of December where there was a lot of chitter chatter of a lot of stuff going down on the streets where
4:53Speaker 2Red or True Tide,
4:55Speaker 2know, all the GLP-1s and things like that. So we had
4:58Speaker 2a great conversation and a lot of the things that we've kind of talked about at that time are kind of to a degree come to fruition
5:06Speaker 2now.
5:07Speaker 2Not to say go us, we just, you know, kind of have some of the foresight into that stuff, but I do, I want to kind of, you know me well, man, I want to cut to the jugular
5:17Speaker 2and, you know, talk about the big fat elephant sitting in the room that everybody probably wants to hear, which is,
5:25Speaker 2what the hell happened to peptide science?
5:28Speaker 4Yeah, that's a great question. And that just all went down this past weekend, right, where when you went to their website, you would see that it said, hey, we're shutting down shop. Thank you so much for all the years.
5:39Speaker 4So allegedly, and I was next to a
5:43Speaker 4couple of really great attorneys that are in the know as this was happening
5:47Speaker 4in real time. And allegedly, what had happened with them was it had nothing to do with with research peptides at all. It actually had nothing to do with peptides whatsoever.
5:57Speaker 4It was allegedly, again, their credit card processing that they were doing offshore.
6:01Speaker 4And it seems that there was something going on where things weren't being reported the way that it should have been, so on and so forth. And again, the best way I can say is, allegedly,
6:11Speaker 4this is what's what's been going down with them.
6:13Speaker 2So allegedly, so you don't feel in any way that it had anything to do with the FDA or any type of regulations or anything like that? It was just strictly a credit card processing. You're absolutely correct, man.
6:26Speaker 3Correct. So let's
6:27Speaker 3stick on credit card processing for a 2nd. Sure.
6:31Speaker 3Tell
6:32Speaker 3everybody, so,
6:34Speaker 3everybody, just so you know, like you go to these different peptide websites and not all of them accept credit cards. The reason is- Well, still.
6:43Speaker 3These peptides are handled kind of like cannabis,
6:46Speaker 3right? The
6:47Speaker 3banks think that customers are super high risk, right? They think that the customers buying peptides are super shady for some reason, doesn't make any sense, but it's a good way for banks to the banks know that there's a lot of money being spent and they can make a lot of money and so they're just gonna do their best to tax it. So essentially like you're a company and you wanna have a credit card processor,
7:09Speaker 3you're paying 10%
7:10Speaker 3of
7:11Speaker 3every dime that you make and they, the bank takes it goodbye, gone. You're taking another, they're taking another 10%
7:18Speaker 3and paying that back to you 6 months later,
7:22Speaker 3assuming you don't have any charge backs, right? So every dime that
7:26Speaker 3a company makes, they take 20% of it right then and there. And
7:30Speaker 3that is if you can be
7:33Speaker 3even approved, right? And then you get a processor and it usually stemmed, it usually is there for maybe a couple months max,
7:41Speaker 3and then it gets shut down. The bank goes, oh, you're you're you're
7:46Speaker 3charging too much money or you're accepting just too much money, right, because you're a business and you wanna accept money. Right? I think that's thought that was the point. But,
7:55Speaker 3nope, you're taking too much money, so we're gonna shut you down and all the money that we have in reserve and all the money that we may still have that we didn't give you frozen 6 gonna freeze that. We're freeze it and not give it to you. Yeah. So you'll see a lot of these
8:06Speaker 2product companies
8:08Speaker 3accepting Zelle, Venmo,
8:10Speaker 3catch up, Bitcoin,
8:12Speaker 3and I guess to the viewers like that's not shady.
8:16Speaker 3Realize, I think, you know, a lot of people would say, Hey, if I'm not paying with a credit card, there's something must be wrong. Right? Well, yes, it was wrong, but it's the bank's fault.
8:24Speaker 3It's not like this. The company is the online company is shady. That's just standard. This is just how those are what people do gotta do to try to make a living,
8:33Speaker 3and to get around.
8:35Speaker 3Yeah. It's not even, I mean, it's less about the fees, which are crazy.
8:39Speaker 3I mean, not to mention, so 20% gone, then pay another 45%
8:43Speaker 3in taxes. There's very little leftover for a company to
8:46Speaker 3make. But
8:48Speaker 3it's more about like, God, the consistency,
8:51Speaker 3right? And I always have a new process or blah, blah, blah, getting shut down, frozen. Sucks. So a lot of companies will just resort to Venmo,
8:58Speaker 3Zelle Cash App, and that is what it is.
9:01Speaker 3And crypto. Yeah. FYI and crypto, and I guess direct
9:06Speaker 2like a bank account to transfer, right? Enter an account routing number automatically, and then it can get, you know, people have heard that like, or the ACM clad
9:15Speaker 3that, it's basically an ACH transfer. All those things are just normal standard practice and don't be alarmed.
9:21Speaker 3I mean, always be a good consumer and watch yourself, but
9:25Speaker 3that's about standard for peptides.
9:27Speaker 2Well said. So just FYI to people. I think most people at this point, because, you know, as we all know, sitting here, I mean, peptides have just blown the hell up. I
9:36Speaker 2think most people at this point, you know, if we talked a year ago, that would definitely be a different conversation,
9:41Speaker 2but I think most people are getting it, you know, they're, they're most people are getting that's kind of how it works.
9:47Speaker 2Let me ask you this. What do you think, do you think that's going to stay the same? Do you think it's ever going to get better? Probably not because of the gray area that,
9:56Speaker 2those companies swim in.
9:59Speaker 4You know, as long as the gray area stays gray, that's pretty much where we're gonna stay when it comes to the banking.
10:05Speaker 4And that's why going back to last end of last year, the last time that we all met, we were speaking about the changes that were happening with with peptides getting approved,
10:15Speaker 4and now we're starting to see that happening. Right? And we knew that all the rage, and it still is quite frankly with Retatrutide, with the GLP-1s. With Retatrutide
10:23Speaker 4Right. And Eli Lilly, all these companies, big pharma coming in and really creating the monopoly on retrutide,
10:29Speaker 4getting that getting that to go through FDA approval. We really thought that we would see that get FDA approval
10:35Speaker 4earlier this year, and it seems like it's still ongoing. But what we have seen now is, as we mentioned in our last podcast together, about 25 to 40 peptides were gonna start to move out of where they're at in the gray area from the do not compound list. And now Yep. We're seeing about 14 to 19 move into category 1, which means
10:54Speaker 4that they're gonna come back into the compounding pharmacies of 5 0 threes where a doctor can write a prescription for those and get that sent out to a patient. So
11:03Speaker 4that's where I see things are gonna continue to move forward in that regard. And the reason why I say that is because as they get more regulations
11:12Speaker 4to move the peptides into the category ones,
11:15Speaker 4that's where they can control it more and they can have the doctor prescription and guess what else comes with that? Credit card processing.
11:22Speaker 2So that's where they're gonna be able to charge and do those things. Somebody listened to the, to the, to the podcast that, that, you know, is kind of new to peptides and just new to this world.
11:33Speaker 2If you can kind of dissect that a little bit, what does that mean to the consumer? Like, what does that mean towards,
11:40Speaker 2people that
11:43Speaker 2it just, you know, trying to buy peptides and people that have been going through like a research
11:48Speaker 2peptide company compared to like,
11:50Speaker 2you know, if doctors can actually
11:53Speaker 2prescribe those, what's that gonna do to the market? Great questions.
11:58Speaker 4Little bit, and I know that your viewers, if they've seen this a little watched us a few times, I won't be too much of a broken record, but just a little bit about my past.
12:06Speaker 4I was the patient care director for some of the largest online clinics telehealth in the country. Right? So what I would see back in, let's say, 2022
12:15Speaker 4before the do not compound list actually happened for things like Tesamorelin,
12:20Speaker 4BPC,
12:21Speaker 4all of these great peptides that we all know and love. I'll
12:25Speaker 4give you an example.
12:26Speaker 4And it's again, not all telehealth is gonna be doing this, but back then, what what happened was is that 4 months of Tesamorelin
12:33Speaker 4was right around $4,000
12:35Speaker 4supply. Right? And I remember the number vividly. It was $39.74,
12:39Speaker 4$3,974
12:41Speaker 4for a 4 month protocol of Tesamorelin. Now
12:44Speaker 4when you go into a research use website, you're gonna see that same vial of Tesamorelin, for example. Let's, you know, I'll just use round numbers. I'm just making it up. Let's just say it's a $100. Right? Just a $100. Okay. So 4 months of Tesamorelin from that kind of a site is gonna be dramatically,
13:03Speaker 4infinitely less than paying 4,000 So
13:05Speaker 4that's gonna be the major difference that that folks will see. The beauty is is that us living in America, we have the freedom of choice. Right? So but the there's there's a Latin saying called caveat emptor, which means buyer beware. Right? That's in everything that that we have here in The United States. So that means that you need to be educated as a consumer to understand where you're getting your peptides from, how you're getting them, where they're sourced from, and is it a trusted source?
13:30Speaker 4And then move forward in that regard. But, yeah, that's that's a great question, JD. So when it goes into the 5 0 3, the compounding pharmacies, and then it's gonna go through a doctor's prescription, you might see a little bit of a price change. Yeah. Mhmm. I'm thinking, like, you know, you gave us the round number, and it's about right. So I'd say for about 3 months to Tesamorelin on a typical research site, you're probably paying about $600.
13:51Speaker 2Right? Maybe 2 bottles a month We'll get you about 2 bottles less a month. So yes, 600 is a awful lot less than 4,000. Little bit. Little bit. More
14:03Speaker 2hands got to get into the pot through that route. Right? Let me ask you a question, man. Mean, if the government touches anything, does it get cheaper?
14:11Speaker 2No. I'm
14:12Speaker 248 years old. I haven't seen it yet, but it might be coming. So Pogue, off the top of your head, tell us,
14:18Speaker 3if you know, what are those 14 to 19 peptides?
14:21Speaker 4Do your best at that that giving us a list of which ones You know what, I actually wrote the entire list out the other day and if you put a gun to my head,
14:28Speaker 4only 1 that I'll remember right now is BPC. BPC. Alright. But it's
14:33Speaker 2most of the big popular ones. Yes, is. Sure. Yeah. Okay.
14:39Speaker 2Figured. Yes. Good. So what's that going to do? Because I
14:43Speaker 2mean,
14:43Speaker 2has their favorites and I think, you know, the gateway drug, so to speak, for a lack of a better way to say it, is either BPC
14:50Speaker 2TB-five hundred or
14:53Speaker 2any 1 of the GLP-1s.
14:54Speaker 2You know, a lot of people start there for rightfully so. You know, they, they try those, they work really well. And then they try multiple peptides is what, you know, what we see often.
15:06Speaker 2But people are going to want to know obviously about the GLP-1s,
15:10Speaker 2obviously specifically Retatrutide.
15:12Speaker 2What is this going to be? What is this going to mean for that? Like, what does this, this whole, what does all this do
15:20Speaker 2for Retatrutide?
15:21Speaker 2It's been supposed to be FDA approved,
15:25Speaker 2it's been pushed out, but as we move forward in 2026,
15:29Speaker 4what's your foresight? What you think's happening? What's that going to do to Retrutide? Well, we know what's gonna happen is is once the final approval comes down through the FDA because of all the clinical testing and trials that they've run,
15:42Speaker 4from big pharma on Retrutide,
15:44Speaker 4that is their that is gonna be their drug. They own it. They've taken it through all the trials and testing. They own it. And that means what does that actually mean when I say that that's their drug? It means that they're gonna be the only ones that are going to be able to compound and supply it. So if you want Retrutide,
15:59Speaker 4you're gonna be going through Eli Lilly. Right? And they're gonna be the ones that are gonna send it down to the compounding pharmacy, from their compounding pharmacy, from the doctor's prescription to go out to the patient.
16:08Speaker 4So does that mean that there's going to be other variations of a triple agonist
16:14Speaker 4glucagon like peptide 1 compound out there that could potentially be mixed with something else?
16:21Speaker 4Of course, there will be. Right? Right. And then how long does that last? We don't know. That's why it's kind of this this guessing game, if you will, where we're trying to see how long you're gonna have access to it. But at the end of the day, will access always be there for Retrutide? Yes. But it will be through the big pharma and a doctor's prescription. Will there be other avenues?
16:41Speaker 4Yes, but you don't know how long that'll last because if there's 1 thing we know about big pharma is that they don't play around when it comes to their drugs that they paid for.
16:48Speaker 2Yeah, they're pretty big. Price will skyrocket.
16:52Speaker 2They wanna run this prescription only. They wanna run the price. I mean, it's supply and demand. Right? If they have all the supply, they can demand whatever price they want and people will buy it. That's typically how monopoly works, man. Yep.
17:05Speaker 3And I will play devil's advocate real quick. Like,
17:08Speaker 3I know people like, oh, bad, big pharma. Well, I will say that, they did spend a lot of money and develop this drug themselves, and so they do kind of have the right for to do the drug. So Yeah. And you can understand they there's a lot of bloods blood, sweat, and tears that they put into into that. You're 100% right, Will. And 1 thing I wanna mention to you guys, just just to point this out to the audience,
17:30Speaker 4is that,
17:32Speaker 4look, when it comes to peptides, right, and people go, oh, it's not FDA approved, this, that. Okay. So let's break that down.
17:40Speaker 4Aren't vitamin c, b 12, creatine,
17:43Speaker 4protein. None of these are FDA approved either. Right? But we all use them on a daily basis. The other part of this is
17:48Speaker 4that when it comes to FDA approval in peptides,
17:53Speaker 4does that mean that a peptide is not gonna be efficacious
17:57Speaker 4or safe, or does it mean that it's not gonna be something that's gonna be life changing just because it's FDA approved? Absolutely not. We all know that. Right?
18:04Speaker 4But what you have to think about is why is it not FDA approved? Let's talk about that just for a moment. Why is it not FDA approved? Well, some of these peptides aren't gonna be FDA approved, not because they don't work fantastically well. It's because there's no money in it for big pharma to do something about it. But why is Retatrutide
18:21Speaker 4and these GLP-1s
18:23Speaker 4looked at so profitable?
18:25Speaker 4Right? And and for them to want to FDA approve it is because it's actually projected that Retatrutide
18:30Speaker 4alone in the next 10 years is gonna be 1000000000000 dollar compound.
18:34Speaker 4So that's the big difference that I just want the audience to really think about and know. It's not that they don't work. It's not that they're not safe. It's not that they don't make sense. It's just that there's no money in it for them to want to take it through the clinical trials
18:46Speaker 4for the FDA approval. So that's a big difference, guys. That's good. That's thank you for that clarification.
18:52Speaker 2Yeah. And that, so that happens. So, so they, it gets FDA approved. Yeah. Lilly is the king of the castle, so to speak. What's that do to the other peptides?
19:02Speaker 4What's that do to the rest? What's that do to the other peptides? Meaning
19:05Speaker 2like, are
19:07Speaker 2like research companies
19:10Speaker 2going to be still in existence? Do you think those will fall at the wayside?
19:14Speaker 2What do you think those will do for, smaller companies? No, great question. So when, once that approval happens,
19:22Speaker 4I'll say this,
19:23Speaker 4will the research companies still be in existence? Yes. But they're gonna be playing that fine line when it comes to to things like GLP ones and and whatnot because Yeah. If they start to go down the route of
19:35Speaker 4making too much noise or marketing in the wrong way when it comes to GLP ones, they're gonna get that cease and desist really quick from big pharma.
19:44Speaker 2Okay. But,
19:46Speaker 2you know, peptides have grown so fast and so much.
19:49Speaker 2The obvious reason is because they work. They are freaking amazing.
19:54Speaker 2They are healing people
19:57Speaker 2with so many companies and just like any company, I mean, like
20:02Speaker 2sports companies, you know, where they sell footballs, whatever, some are good, some are bad, right?
20:06Speaker 2But
20:07Speaker 2with that many companies able to get access and whatnot, I mean, can they even, I mean, can they dent that many companies? I mean,
20:16Speaker 2you know what I mean? They don't have they don't have that much manpower
20:19Speaker 2to be able to stop the sale of that product.
20:22Speaker 4No. And you'll be surprised, right? Because the things that they're looking at is who's the biggest players in the industry. Right? So I'll give you guys an example. I have some insider information that I know, and now that Peptide Sciences is defunct, I'll I'll talk about this. But we know that back when we met last time in December,
20:39Speaker 4a couple months before that was was a a big we'll just say a big summit. I'll I'll let everybody use their their spidey skills on on thinking about what it is that I'm talking about that went down in DC back in, like, September, October time frame. And
20:55Speaker 4Big Pharma literally told Peptide Sciences, hey, guys. We we've got a cease and desist ready for you guys come January.
21:01Speaker 4Because once January happens, we're not gonna allow you guys to make the triple agonist or GLP r, GLP 3, whatever you guys wanna call it because we know what you guys are doing, and that is now gonna be our drug. Right? So that's who they're looking at more than anyone. And as long as Chronic migraine, 15 or more headache days a month, each lasting 4 hours or more, can make me feel like a spectator in my own life. Botox, onabotulinum
21:23Speaker 1toxin A, prevents headaches in adults with chronic migraine. It's not for those with 14 or fewer headache days a month. It's the number 1 prescribed branded chronic migraine preventive treatment.
21:33Speaker 2Prescription Botox is injected by your effects of Botox may spread hours to weeks after injection, causing serious symptoms. Alert your doctor right away as difficulty swallowing, speaking, breathing, eye problems, or muscle weakness can be signs of a life threatening condition. Patients with these conditions before injection are at highest risk. Side effects may include allergic reactions, neck and injection site pain, fatigue, and headache. Allergic reactions can include rash, welts, asthma symptoms, and dizziness. Don't receive Botox if there's a skin infection. Tell your doctor your medical history, muscle or nerve conditions, including ALS Lou Gehrig's disease, myasthenia gravis or Lambert Eaton syndrome, and medications, including botulinum toxins, as these may increase the risk of serious side effects. Why wait? Ask your doctor, visit Botox Chronic Migraine dot com, or call
22:14Speaker 440 to learn more. These other research companies are doing the doing the right thing and marketing the right way and playing by the rules, they'll be fine. But the 2nd they go into
22:25Speaker 4hitting the pockets of big pharma, that's when they're gonna get in trouble. Peptide Sciences sales were probably responsible for well, let's just say, you know,
22:34Speaker 3maybe this is kind of even more of an
22:37Speaker 4in proportional eightytwenty rule, but like Peptide Sciences and a few others were probably responsible for 98% of the total sales. Probably a safe bet. You know, it was Of that company. Of that company. It was rumored or or, you know, again, I love the word allegedly right now as my attorneys tell me to say all the time. But it was it was allegedly
22:54Speaker 4they were, they were doing about, you know, dollars $210,000,000
22:57Speaker 4in revenues a year.
23:01Speaker 2Not, not to cut that short, but I heard more about that's a man. You're doing all right. Yes. Yeah.
23:07Speaker 3And I've had yes. Anyway. And they were taken down by our credit card partners. Yeah. Credit card I guess I want to touch before we forget, I guess I want could you please clarify the difference between these 14 to 19 peptides that we're saying that you're saying are, you know, being pushed through and
23:23Speaker 3Retatrutide's
23:25Speaker 3approval. Right? There's a huge difference on the approvals. We're not talking about the same approval.
23:29Speaker 4Back in 2022,
23:32Speaker 42023,
23:33Speaker 4when big pharma was essentially pulling on the strings of their lobbyists down at the FDA to to tell the FDA, hey, guys. Put all of these peptides on the do not compound list because essentially what they were doing was they were looking into these peptides.
23:46Speaker 4They said for safety, for efficacy, for efficiency.
23:49Speaker 4Some may argue that it was so that they could figure out how to patent some of these or take them through the, the approval process so that they could control it like what we're seeing with with Retatrutide. Right? Some may say that.
24:00Speaker 4The thing is is that when it comes down to the difference between what what they're doing with retrutide and getting its FDA approval,
24:07Speaker 4that means that it's gonna be with a prescription through a doctor, FDA approved, they own that drug.
24:13Speaker 4The 14 to 19 that are now being stated that they're going to put into category 1. So what does that mean? It means that they're taking them off of the do not compound list,
24:24Speaker 4and then they're going to allow the compounding pharmacies, the 5 0 threes that we that we keep mentioning,
24:29Speaker 4allowing the 5 0 3 pharmacies to compound them again the way that they were doing back in 2022.
24:35Speaker 4And I wanna say it was and it stopped back in '23 or maybe it was '22,
24:40Speaker 4because I remember when it was when it happened
24:43Speaker 4because I was still, you know, neck deep in in telehealth at that time.
24:47Speaker 4And when they did that and they put them on the do not compound list, that meant that no doctor, no compounding pharmacy could make them anymore. And that's when they went into really heavily into the research space.
24:59Speaker 2Right. So
25:01Speaker 2again, what's that going to be due to the price? Up.
25:04Speaker 2You know, there I'll give you I guys know that's rhetorical
25:07Speaker 2to me, but I know there's people asking that don't know. They're always gonna
25:11Speaker 4the scariest thing in the world to me besides besides, you know, war and everything like that, but 1 of the scariest things in the world to me is when the government knocks on your door and says, hi, we're from the government. We're here to help.
25:25Speaker 2A Reagan
25:26Speaker 4quote, baby. Yeah, man.
25:28Speaker 2Telling it. That's great. With,
25:32Speaker 2with,
25:34Speaker 2peptides just being as amazing as they are,
25:38Speaker 2This is obviously just a personal question. Do you
25:41Speaker 2think they're going to start pushing pharmaceutical
25:44Speaker 2out?
25:46Speaker 2You know, I mean, pharmaceuticals are gonna be always be there, but like they work so well and they're so healthy.
25:52Speaker 2And,
25:53Speaker 2you know, with some of the pharmaceuticals
25:56Speaker 2that people take, they're destroying our guts. There's such a movement for people to get healthy.
26:02Speaker 2People feel like shit, you know, and like they start taking peptides, they start like, Oh man, I forgot what it feels like to feel good again.
26:10Speaker 2So with the power
26:12Speaker 2of
26:13Speaker 2how amazing those are, what's your take on, do you think they're going to push
26:20Speaker 4Western medicine to a degree to the side? I mean, if you break your arm right, you need a doctor, but like, you know what I mean? Does that what do you think about that? Brother, I'll say this. We can only hope that it does. Right? We can only hope that it does. And just this last week, a study came out. Right? This is public information, so everybody can just look this up. There was a document that came out from the CIA
26:42Speaker 4that they had found a cure for for cancer.
26:46Speaker 4Now it's not that they found a cure for cancer that was a big issue. The issue about that document was that it was 60 years old.
26:54Speaker 4Yeah. Yeah. Yeah. You know? So we can only hope that that's what's gonna happen. No. No way. Shocker.
27:00Speaker 4Right? No way. You blew my mind. The thing is, man, is that when it comes to peptides and the reason why they're so popular and the the reason why we can only hope
27:10Speaker 4that they will really push Western medicine towards this this route as opposed to, you know, just putting a Band Aid on things with pharmaceuticals.
27:18Speaker 4And the reason why it's happening, is because of guys like you
27:22Speaker 4and the people that are listening to this podcast
27:24Speaker 4and the people that are actually talking to their doctors and bringing it up. Right? Because I can't tell you how many
27:30Speaker 4professional
27:31Speaker 4medical doctors and surgeons that I speak to that don't know about peptides that are now hearing it from who? Their patients,
27:38Speaker 4their clients. Right? And that's what's really pushing this forward. So we just gotta keep up the good work that everybody's doing here with working from their heart and going, hey. Peptides are great. They're signaling molecules that are actually working and healing people. Let's talk about it. And that's what's making the feds and everybody look at it as well. But yeah, we can only hope that it's going to push that Western medicine in that way.
27:58Speaker 2Yeah, Duche. I, it is, it's funny you say that because, know, it's not only that, it's
28:05Speaker 2baffling that
28:07Speaker 2the amount of medical doctors that people go to see, and we trust them, you know, we have trusted them now. I think that trust in the last 6 years or so has been shaken obviously from most people.
28:20Speaker 2But it's amazing the amount of trust that we gave doctors
28:24Speaker 2to just take these pills and, you know, just have destroyed our guts and our gut biomes and whatnot. And it's amazing to me and Will and I talk about this all the time to the point of nausea, but we love it. But even
28:37Speaker 2the fact of the doctors that don't have a clue about any type of hormone levels or like what's a healthy level or
28:45Speaker 2a man that's at 2 50. They won't prescribe testosterone
28:50Speaker 2replacement.
28:51Speaker 2I mean, now there's a movement and it's just like peptides.
28:55Speaker 2Some of the doctors that are using the brain are seeing the train coming and they're starting to get it.
29:03Speaker 2And I mean, shoot, we have doctors that listen to this podcast that, you know, like we're not doctors, we're just 2 dudes. We've just, for
29:12Speaker 2lack of better word, studied it for years because we were so intrigued by it, you know, and it's still studying it that, you know, but we still like, we do know more about than doctors because they don't open their minds to it. They don't, lot of doctors don't even know about nutrition because they've never studied it.
29:28Speaker 2You know, that's, it's just kind of amazing that we've given them so much trust. But like I said, I mean, I think there's such a movement within
29:37Speaker 2the world, at least The United States, but I think the world to get healthy again, truly healthy. I think people are sick of feeling like shit for lack of a better way to say it. And they are seeking different things. That's why this podcast has grown quickly. There's nothing special about these 2 dudes sitting here.
29:55Speaker 2We just have shined a light on some things that people didn't know, and now they are starting to seek deeper.
30:02Speaker 2And it's like that,
30:04Speaker 2that rabbit hole, so to speak, that everybody has to go through. And then that cognizant breakthrough that we all finally get through and it's like, the world's so different than I thought. You know what I mean? No, man. And you know what, JD, to your point, I want to I want to tell you guys this because, look,
30:19Speaker 4not only do I love working with you guys, but obviously I'm a fan. I watch what you guys do. And the change that's happening right now is when when patients, when people are actually speaking to their doctors and they're bringing up peptides to them. Yep. You need to watch the way that doctor reacts. If they just brush it off, they don't wanna talk about it. Right? That's not a great sign. But if they start to open their mind, they go, oh, well, tell me more about that. Let me do some research and get back to you. That's huge. And my hat is off you guys because I watch your podcast, obviously. I'm a fan 1st and foremost. You guys have had the right kind of doctors, the right kind of medical professionals on your podcast that are talking about this stuff, and they go, oh, yeah, man. I get it. I understand. I see what's going on. I hear you guys. I know what you guys are up to. So that's what really matters, and that's what's pushing this conversation forward for us to, you know, no pun intended, for us to literally make America healthy again.
31:06Speaker 4And it's and it's working, Yeah.
31:09Speaker 3That's true, man. So in my, in my free time, I like to do things things that maybe people would say I'm a nerd, but I was like having, I was writing like a mission statement for this
31:18Speaker 3podcast, right? And
31:20Speaker 3as I thought about it and wrote it more, like literally the mission
31:24Speaker 3for me is to basically like further, is to further R and D of peptides. Like that
31:30Speaker 3is the bishop, right? These aren't controlled tests, but really to just get out more research and development. Right?
31:36Speaker 2Well, research,
31:38Speaker 3with the masses, because that's the only way that we're really gonna people are gonna find out about peptides and how really they work and etcetera, etcetera.
31:47Speaker 3Not to make money like we sure as hell didn't start this podcast
31:51Speaker 3thinking about making money.
31:53Speaker 3But really, yeah, kind of the impetus there is to kind of just further the research and development of peptides in general
32:00Speaker 3and see where that takes us.
32:02Speaker 3Because there's a whole bunch of good stuff that these things do. Speaking of, did you see did you see the podcast that we did with, with Lee,
32:10Speaker 3who is the owner of the,
32:13Speaker 4what's name? Yeah. Wellness Center. Service. Yes. That's actually what I was referring to, man. We wanna I agree because I do that, and I go, well, you guys are getting the right people on there. Their their light bulbs are going off and they get it. Right? Yeah. And to your point, Will, the other thing I wanna I wanna give you some some flowers for is the kids are saying these days. Right?
32:31Speaker 4I saw 1 of the posts that you made. I don't know if it was a post or a podcast,
32:35Speaker 4but you were talking about Dihexa, and I couldn't be any more proud of what was going on. So full disclosure to the audience, JD and Will, they they suffered. You know, I was gonna say they suffered through my training of of of all the peptides and stuff, so God bless you guys. But what you're doing with it now, where you've taken it, I go, dude, look at these graphics. Look at what they're talking about. He's talking about the dendrites and synapses. I loved it, bro. I was I couldn't move out. Wait. Yeah. We got more I got more coming. I was just working on my tuning in. Comparing
33:03Speaker 3I I thought, frankly, that we were gonna do this and do, like, a compare contrast of the GLPs. And so dude, I got some cool, I had some really cool graphics. I did see that with Lee. I did see that. Yeah. Okay, cool. Yeah. It's so funny, Paul, because you've known us, you know, from the conception of this company and
33:23Speaker 2the genesis of this is, us being in Vegas and I'm like, well, we need to sit down and we need to talk about a peptide for like 10 minutes, dude. And then I think it was going be for my YouTube. And then we did a couple, like we tried doing it on the beach. We were going to do it on a different beach in Orange County. Like, you know, that's how everything starts. You just start tying things and the people are like, I can't hear it, you know? And then like,
33:43Speaker 2just started doing it and then like over, I'd be at my office at home. He'd be out the office, you know, our old office. That
33:49Speaker 2was just the Genesis of it, And it's funny because he will, will is just, you know, he was a little bit kicking and streaming doing it because he didn't know this neither of us had a clue this would turn into even something. Were at a studio now because it's done so well, but
34:05Speaker 2it's because
34:07Speaker 2I believe that when you try to do good, regardless, God puts his hand on it, you know? Absolutely. So it's been a blessing,
34:14Speaker 2you know, and then we get to touch the people that listen
34:18Speaker 2on the Q and A's because they write in and do there's people in Scotland, there's people in like Australia and it's like, it's rad, man. People are seeking health
34:28Speaker 2all over the world.
34:30Speaker 2To be a little piece of some of that as a blessing, man, all 3 of us dude, like sometimes,
34:35Speaker 2man, I wake up, prayed, I'm meditating stuff. And I'm like, I just look up. Thanks, man.
34:40Speaker 2Appreciate you. God's hands are all over it, bro. Any new, any new, I know we asked this last
34:47Speaker 2peptides coming down the pike? Anything new? Because you always have your,
34:51Speaker 2you know, nose to the grindstone a little bit, you know, and and know what's coming down. Anything new coming? I'll give you guys 1 that I actually just started
34:59Speaker 42 days ago.
35:01Speaker 4It's it's actually a a
35:03Speaker 4different variation of Follistatin,
35:05Speaker 4FLGR
35:06Speaker 42 2 4, and I'm maybe butchering that a little bit. Campbell talking about this all the time? Jay Campbell?
35:11Speaker 4That 1 you know who, Brian Moscow is? Good friend of mine. He's a biochemist out from UC Berkeley. Super brilliant guy.
35:18Speaker 4And he's the 1 that actually
35:20Speaker 4brought that to my attention, and I've seen some pretty amazing stuff with that, man. Amazing stuff. Guys putting on 20 pounds and I go, know what? I'm gonna try that out myself. So I'm, that's why I hit you guys up earlier today and I go, hey, man. I I need to pick up some other stuff so that I can I can get this this spring summer body going? You know? We're never too back from the Arnold Classic, Doug. Yeah. Exactly. Exact. After being at the Arnold Classic, I go, I gotta get my stuff together, man. Yeah. That's right.
35:47Speaker 3No doubt.
35:48Speaker 3Well, that's cool, man. I'm gonna look into that. What's name of that
35:52Speaker 4again? FLGR-two
35:54Speaker 424.
35:55Speaker 3So,
35:56Speaker 3speaking of kind of follistatin ish, so we have a good friend,
36:00Speaker 3who's actually been on this podcast before,
36:03Speaker 3but so you know those Belgian blue bowls? Yes. So you've seen pictures of these bowls that look like somebody's been just injecting them with nothing but steroids forever,
36:12Speaker 3just rippled out with muscles. Well, that is like a natural condition for those bulls. Yep. They,
36:17Speaker 3in their genes, they just have something that does not shut off, doesn't tell them to stop growing muscle, and doesn't tell their body to stop burning fat or at
36:27Speaker 3least their body can't meet, isn't told to
36:30Speaker 3build fat. Right? So doctors have,
36:34Speaker 3in different countries,
36:36Speaker 3have bottled that
36:38Speaker 3and now offer it as an injection to people. So we had a friend who went down to Mexico
36:43Speaker 3and got the injection of it. And it's supposed to be like that 1 injection, but last year 4 years and changes kind of your, how your genes
36:51Speaker 3work.
36:52Speaker 3That's exciting. You just, that's exciting right there. I don't think he said he felt anything though. He didn't. I think he did. You know, he here's his plan. He's like, yo, yeah, bro. Like, I remember him trying to justify the money portion of it and be like, look, yeah, I know it's 5. It's like $15. Right? But
37:07Speaker 3the all the money I spend on supplements, right, on all of my, like, tests and peptides, etcetera,
37:14Speaker 3I don't have to do any of that stuff. I just got this. Right? And I just don't think that he really got a good result because of course he didn't stop all the other shows. Right? We
37:22Speaker 2love you, buddy, if you're listening. I'm
37:25Speaker 3always supposed to say that, but they don't, at the end of the day Yeah. Don't stop at all. Yeah. And I think at the beginning, I haven't talked to him recently, but he did say he noticed it. Now he sure didn't look. I mean, he didn't put on 60 pounds of just pure muscle, and he was already in good shape. He was all he's always been in really good shape. So I don't know. I don't know if
37:44Speaker 3I don't know how well he really said it worked, but I think he did say it worked a little bit. Know.
37:49Speaker 2Good.
37:50Speaker 41 thing I just was gonna tell you guys that I that I've said for years in all in all the years that I've been in in telehealth and even now when I'm when I'm talking to folks 1 on 1 that asked me about peptides or they might go, hey, man, this kind of didn't work or I don't know if this was working. And I I will point blank look at everyone in the eye and I just go, listen,
38:08Speaker 4all these compounds, these medications, you know, if you're on hormones, peptides, whatever you're on, they're wonderful. They will work. But let me say something, They will only work as hard as you do.
38:19Speaker 4That's it.
38:20Speaker 2My drop dude. Like, dude, like you can't sit on the count and chat to not change your life, dude. I mean, we talk about it so much, Paul, like 1st and foremost, if your hormones aren't optimized,
38:32Speaker 2dude, and you're over 40, you're doing it wrong. Like you are swimming up a hill or you're just walking up a hill or swimming and it's a stream, like get your hormones in line and for the love of God, the obvious is workout and eat right. Like change your darn lifestyle.
38:47Speaker 2And then the peptides will fly.
38:50Speaker 2They will be amazing. Amplify.
38:53Speaker 4Might work a little bit. Why would you want it to work a little bit? They're not cheap. Like, if you're gonna do it, do it well. 100%. And you're the shining example of that, JD. You actually live and walk it and talk it and do you practice what you preach, basically, is what I'm saying. And the thing is is I go I go when people tell me, oh, I just lost, like, 8 pounds, and I go, you lost 8 pounds and did nothing? I go, 1st of all, that's amazing.
39:14Speaker 32nd of all, imagine if you actually did something, like, how much more you would lost and how much better you would have felt. So yeah, man. Or we hear this a lot. Like, it's just it didn't do anything for me. You know, I've only lost 20 pounds in 2 months. So it doesn't work.
39:28Speaker 3Seriously. Like, it's only 20 pounds. Are you listening to yourself? Right? Yeah. How long did it take you to gain that weight? Anyway,
39:35Speaker 3yeah.
39:36Speaker 2Agree. It's like funny because, you know, any GOP-1will
39:40Speaker 2give instant gratification,
39:42Speaker 2but it's like, I want more.
39:44Speaker 2Sit on the couch and I'll do shit, eat some Twinkies and lose 50 pounds in a week.
39:48Speaker 4If only.
39:50Speaker 3Yeah. So, hey, Paul, what are your personal
39:53Speaker 4top 5 peptides? Just how about in life, what do you actually take? What are your top 5 peptides that you mostly take? Let me take a jab at this. Right now what I'm doing- See you again. Great. I love this question because you guys already know. Was we were talking before we started the podcast. I was like, hey, guys. I gotta get my stuff together. You know? And and thanks for pointing that out that that it was Arnold Classic that did it to me. That was a good motivator right there. But Yeah. The I'll tell you. For me right now,
40:18Speaker 4what I'm taking is I'm taking SLU-3P,
40:21Speaker 4right, the exercise mimetic.
40:23Speaker 4Really like that 1. I take a milligram of that in the morning fasted.
40:26Speaker 4And then I take that with 150 mg of 5 amino 1 m q oral, both of those.
40:31Speaker 4That's gonna go after the white adipose tissue, that that stubborn body fat. Right? Because,
40:36Speaker 4you know, hey, man, I'm I'm Persian. I'm 44. I keep the love handles no matter what I do. So I that that those 2 right there helped me out tremendously.
40:43Speaker 4While I'm doing that, of course, I'm like everyone else where I'm trying to lose body fat and gain muscle. So what did I add into that? What you to add? Was the FLGR that we were just talking about. Okay. Got that going and a little bit of Tesamorelin in addition to my 200 mg a week of test Cypionate bio identical from my TRT. So that's what I'm doing right now.
41:05Speaker 4Hell yeah. Thank you. Nice no Retatr for you. Good. Okay.
41:08Speaker 4Right now I go, you know what, let me get this going and then I'll start to microdose Retatr about a milligram, maybe a week every other week because I'm such a small guy. I'm only like five'nine, 180 pounds. I'll wither away, you know?
41:20Speaker 3Yeah, for sure. Hey, now speaking of Dihexa, so in
41:24Speaker 3the presentation and podcast we did, Like Dihexa is not
41:28Speaker 3kind of 1 of the main points there was like, this isn't something you don't take this for like, I'm take it right now and my brain is going to be bang firing, right? Like Modafinil.
41:37Speaker 3Okay. It's a But that being said,
41:41Speaker 3you, I know that you have taken it like before a presentation to make it to for instant results. I also was just literally last night was talking to an employee of ours and she said,
41:52Speaker 3dude, the Dihexa is awesome. She feels it right away and focus.
41:57Speaker 3And I thought that was interesting. It just just shows again, like the research that we do is like,
42:04Speaker 3you know, you can say 1 thing on paper. Yeah. But
42:07Speaker 3but actually, when people take it, oftentimes
42:10Speaker 3things are a bit different.
42:12Speaker 0I think that's cool. Now I do think it's again Chronic migraine, 15 or more headache days a month, each lasting 4 hours or more can make me feel like a spectator in my own life. Botox, onabotulinum
42:23Speaker 1toxin A, prevents headaches in adults with chronic migraine. It's not for those with 14 or fewer headache days a month. It's the number 1 prescribed branded chronic migraine preventive treatment.
42:33Speaker 2Prescription Botox is injected by your doctor. Effects of Botox may spread hours to weeks after injection, causing serious symptoms. Alert your doctor right away as difficulty swallowing, speaking, breathing, eye problems, or muscle weakness can be signs of a life threatening condition. Patients with these conditions before injection are at highest risk. Side effects may include allergic reactions, neck and injection site pain, fatigue, and headache. Allergic reactions can include rash, welts, asthma symptoms, and dizziness. Don't receive Botox if there's a skin infection. Tell your doctor your medical history, muscle or nerve conditions, including ALS Lou Gehrig's disease, myasthenia gravis or Lambert Eaton syndrome, and medications, including botulinum toxins, as these may increase the risk of serious side effects.
43:09Speaker 0Why wait? Ask your doctor, visit botoxchronicmigraine.com,
43:12Speaker 0or call one-eight hundred-44Botox
43:14Speaker 3to learn more. Things where it may not work for me that great because I take too many stimulants. Right? I'm drinking coffee too much. There's too much thing too many things that are actually overpowering
43:24Speaker 3it. But
43:26Speaker 3like her, she was very clear. Like, she's clear and isn't taking much at all, just adding Dihexa and damn, she said she notices a lot.
43:35Speaker 4Is a great question. I've dealt with this a few times. So
43:39Speaker 4I like to pair Dihexa with a couple of other peptides. Right? So if it's someone that goes, hey. So I'll give you guys an example.
43:47Speaker 4There was a patient years ago when I was when I was, at a different telehealth company that he was going through med,
43:55Speaker 4law school, I believe is what it was. He was in law school. And he's like, Paul, he goes, I I don't wanna take Adderall. I really wanna take something that's gonna be natural, something that's a peptide. What can I do?
44:06Speaker 4So for him, what we did was we did 30 mg
44:09Speaker 4of Dihexa daily,
44:11Speaker 4and then we paired it with either I think we started them off at 0.5 a milligram of Tesofensine and worked our way up to a full milligram of Tesofensine.
44:18Speaker 4You put those 2 things together,
44:20Speaker 4that's just fireworks going off in your brain. And you you're able to
44:25Speaker 4not only focus, but you're able to pay attention. And also the best way they can explain is you can move from task to task very easily
44:32Speaker 4without
44:33Speaker 4slowing yourself down. So Tesofensine
44:36Speaker 4being that it's it's what we would call like a natural SSRI
44:40Speaker 4kinda gives you an overall sense of well-being. You feel happier. But what it's really doing to give you a great kick of energy
44:46Speaker 4is it's raising your basal metabolic rate, which is your your your rate at rest. Right? So it brings that up by about 5 to 10%.
44:54Speaker 4And Sure.
44:55Speaker 4It's a great appetite suppressant. So, also, that's just a kind of a pro tip for anybody that's getting off of a GLP 1 that's a little bit nervous about, hey, I don't wanna put on, you know, weight again. Bring in Tesofensine.
45:05Speaker 4And when you pair it with Dihexa,
45:07Speaker 4that's incredible. That's quite frankly, guys, full disclosure, that's how I've gotten through so many seminars. Let me tell you. All these seminars and conferences I've been to is, yeah, the Dihexa and Tesofensine.
45:17Speaker 4And then,
45:18Speaker 4to your point, Will, and I know we've we've talked about this before, when I'm presenting and when I'm actually speaking,
45:24Speaker 4for for doctors that receive their continuing education credits on peptides,
45:28Speaker 4that's where my nerves kick in. Right?
45:31Speaker 4Because as you guys said, none of us here are are MDs or DOs. Right? So the thing is is that I will always cite all of my work, do the clinical research, show the peer reviewed medical studies.
45:42Speaker 4And as I'm going through that, when I'm on stage talking to a group of, like, a 100 doctors, you know, nerves start to kick in a little bit. So what do I do in that in that regard? Was, well, I like to pair Selank,
45:52Speaker 4which is an antianxiety
45:53Speaker 4peptide with Dahexa. Keep me focused, make me feel like right where my feet are at. And that, that that's a really great combination, but Dahexa is fantastic. So
46:03Speaker 4the reason why Dahexa is a really incredible
46:06Speaker 4peptide is because they're studying it for Parkinson's, for Alzheimer's, for dementia. And I've actually seen the effects on on a
46:14Speaker 4person with dementia, a really good friend of mine. His father was 81 years old. He since passed.
46:19Speaker 4But before he passed a good, year or 2,
46:23Speaker 4before that, we
46:24Speaker 4actually had him on on quite a few peptides and brought him back from dementia.
46:29Speaker 4And he was actually
46:30Speaker 4yeah. It was incredible, man. We we did a lot of things for him. Huge. Yeah. What was the dosage? What was the daily dose orally that you guys At 30 I gave milligrams. And that's and just so that you guys know,
46:42Speaker 4before these peptides went on the do not compound list,
46:45Speaker 4because you gotta remember, since since my days in in all of the the telehealth companies that I've been at, so there's something called the SOAP notes, subjective assessment
46:54Speaker 4plans, right? That's what the doctors write in every chart for a patient.
46:59Speaker 4So within those SOAP notes, what's going to be in there is dosing, timing, frequency. So the dosing, timing, frequency that I'm always speaking about is actually what was clinically
47:08Speaker 4recommended and prescribed
47:10Speaker 4at the level of telehealth for these peptides before they went on the do not compound list. So what were we talking about for Dihexa back then? 20 to 30 mg a day. For how long? We
47:21Speaker 4would prescribe everything in 4 month increments. Every peptide I'm always going recommend 16 weeks.
47:26Speaker 4Yep. Okay. Got it.
47:27Speaker 2Nice man.
47:29Speaker 2Oh, I got last question. So I was just curious. And
47:33Speaker 2you kind of answered it, but I want to kind of still ask it.
47:36Speaker 2You know, there's still people that, you know, are so,
47:40Speaker 2so don't
47:42Speaker 2know anything about peptides and they compare them to steroids and all that stuff. Right?
47:47Speaker 2How far away, and you kind of answered it with FLGR,
47:50Speaker 2but how
47:51Speaker 2far away do you think science is of
47:54Speaker 2getting
47:56Speaker 2peptides into the degree where they somewhat
47:59Speaker 2compete with like some Anovar or smaller steroids
48:04Speaker 2that
48:05Speaker 2are going to give you some bulk? Mean, you know, IGF-one, I mean, there's a, know, you know what I mean? But like, we're so far away from like gear that like,
48:13Speaker 2do you think that's gonna happen, I guess, is the 1st question. 2nd is, if so,
48:18Speaker 2when roughly?
48:19Speaker 4So,
48:21Speaker 4again, you guys I love the questions. I was just about to say a great question. I'm I'm like a broken record every time you guys ask me something, but that was a great question. So the thing is is that
48:31Speaker 4there's variations of what we can do with peptides that are gonna be much safer than what we can do with hormones.
48:37Speaker 4Right? So
48:39Speaker 4so I'll give you guys, an example because and to answer your question, we already are kind of competing a little bit in in that regard when it comes to peptides and hormones.
48:48Speaker 4But hormones are are different in the sense that they're controlling
48:52Speaker 4the entire body, right, to where the peptide is controlling a specific mechanism, and it's actually getting the body to perform naturally the way that it wants. So they're just signaling molecules. But I'll give you guys an example because remember, also my background
49:06Speaker 4is in is also from sports supplements and bodybuilding years ago, right, when I was head of marketing for a really big
49:13Speaker 4supplement company.
49:14Speaker 4So
49:15Speaker 41 of the things that bodybuilders really love is growth hormone paired with insulin.
49:21Speaker 4Right? That's a big 1 because that's going to put a lot of size on you, a lot of mass on you. It's going to get you going. It's going raise your IGF levels.
49:27Speaker 4So but it's raising your IGF levels exogenously from outside the body, right, not in a natural way the way that a growth hormone releasing peptide will. Well, what's the peptide equivalent
49:37Speaker 4of GH and SLN? Well, the peptide equivalent that I've actually seen work very well would be MK-six 77, which is ibutamoren
49:44Speaker 4and IGF LR3.
49:46Speaker 4Because ibutamorin is gonna kick up your IGF levels, it's gonna make you hungrier, produce more ghrelin, which is a hormone that that's telling you you're hungry. And then you pair that with IGF LR3, so it's shuttling the nutrients and and food to the muscles that you're breaking down.
49:59Speaker 4The equivalent right there. Now, is it exactly the same? Absolutely not. Does it work in the same regard using the same mechanism of actions? Yes, it does. It's pretty incredible. Do
50:09Speaker 4I think that we'll eventually get to a point toward these that the peptides can
50:14Speaker 4do exactly what the hormones do?
50:16Speaker 4I don't know.
50:18Speaker 4That's a great question. Don't know if we'll get there. I don't know if we wanna get there because we we can always use the replacement therapies of the hormones to do that. But what we are doing with peptides is getting the body to perform naturally the way that it wants to by kicking on its own growth hormone release, whatever it is that we're doing. So like Kisspeptin is bringing up the testosterone,
50:37Speaker 2things of that nature. But yeah, I love that question. Yeah, I'm sorry. Last 1, because now just, I'm actually curious.
50:43Speaker 2So we get a lot of questions
50:46Speaker 2about
50:47Speaker 2high school kids. Okay. And now peptides are so big that,
50:52Speaker 2you know, we have a lot of parents ask us about our opinions on like growth hormones, cretagogues and whatnot.
50:59Speaker 2Without And me, us telling you our answer,
51:01Speaker 2what is your take on that? You have a high school dad that his kid has a great arm and he wants to go, he's going pro, my kid's going pro, you know, like every father thing. And he's 12. Yeah,
51:13Speaker 2right. But let's at least say teens, 15. Let's say 15. 15, 16.
51:18Speaker 4What would you say? What's your opinion on that? I've actually dealt with that exact scenario that you just gave me. Baseball. I've dealt with the baseball bat. Yep. I dealt with that while I was at
51:28Speaker 4the the largest telehealth,
51:30Speaker 4company
51:31Speaker 4in in the country, right, years ago. You're going back maybe, like, 5 years ago, something like that.
51:37Speaker 4So so the so I'll always because, again, I gotta deal with attorneys all the time. So we're gonna go with the legal answer is anyone who's under 21 years old, you can't recommend okay. Now let's talk about if it was my kid. So let's make it personal. Right? Perfect. That's how we do Let's talk about my kid.
51:52Speaker 4Now that's going to be at the discretion of the parent of now the the kid that I'm talking about, he was 17 years old, so he was kinda like right there at that cusp of being 18 and getting in that range. And the dad was like, hey, man. I'm ordering CJC for myself.
52:07Speaker 4And I if I wanna give this to my kid, what do you think? I go, well, look, man. Your kid's already making enough growth hormone as it is. I don't see that something that you should be doing, but you're his father. That's up to you. It's whatever you But wanna
52:21Speaker 4let's take it a step further, guys,
52:24Speaker 4that if it was my kid and he got injured. Let me talk about that. Yeah. Okay. So if he got he or she, God forbid, got injured. Because I have dealt with this.
52:33Speaker 4Folks will ask me this all the time. Hey. You know what? My kid's knee, ACL, MCL, their labrum, whatever it was. Again, not legal or medical advice, but if it was my own kid and they're 16, 17, 8, whatever it is, would I give them BPC?
52:48Speaker 4Would I give them TB-five hundred? There's no question in my mind that I absolutely would. A 100%.
52:54Speaker 2You answered it to the T how we have answered it. That's great.
52:59Speaker 2Either of my sons, I would give them the Wolverine.
53:02Speaker 2To this day, my brother, I have, I have, I have thrown out your protocol
53:07Speaker 2because everybody in the like that's watches knows that I have had back surgery. They're always asking man. I'm glad to help you. I hope afford a
53:15Speaker 4lot, take a lot because it worked well. Was in the gym 2 weeks later and lifting. I love it, man. That's what it's about being able to help everyone out there, man. I appreciate that. But yeah, girl, my dog, I give my dog 1 more time. Yeah, no doubt.
53:29Speaker 3My dog also. So I gave my dog a lot of, TB 500
53:34Speaker 3and I should have given him more
53:38Speaker 3anti cancer
53:39Speaker 3because that's what killed him.
53:41Speaker 3That's inevitably,
53:42Speaker 3you know, you've met my dog, Oscar. He was big. He
53:46Speaker 2was great.
53:47Speaker 3Still running up trees. He was about a 100 pound like Pitbull Rottweiler mix and had a seizure on a Sunday night. By next, by the following Thursday, I put him down and apparently he had cancer in his stomach,
54:00Speaker 3lungs,
54:01Speaker 3and then brain, which is what caused the seizure. But TB-five hundred, a lot of the, a lot of the tests, you know, the, the research actual like R and D and TB-five hundred is, is on canines.
54:11Speaker 3So for his, he tore both his ACLs at 1 point, but 1 of them, I didn't have surgery. I just threatened him like, dude, you need to heal this leg or I might were cutting it off. But I did this $6,000
54:21Speaker 3surgery for the 1st knee and then he tore the 2nd 1, but I never did anything. Gave him, I gave him some TB 500,
54:29Speaker 3man. He healed and never like limped. Was never bow legged. You see a lot of dogs who
54:35Speaker 3they tore their ACLs and no surgery and they're kind of walking bow legged now or limping. I mean, he got old 12, 13 years old and just never even had any leg problems, even tearing both these heels.
54:46Speaker 4It definitely works, man. And you know what? A good friend of mine, you guys also know Trevor, he he recently,
54:51Speaker 4adopted a Saint Bernard, and he thought that the Saint Bernard's hip was was off. He didn't know what was going on, like it had hip dysplasia.
54:58Speaker 4Well, he started giving his dog BPC,
55:00Speaker 4and now he's running up on tables. He can do anything he needs to do. It's it's it's pretty incredible. And also, Will, to your point, you know, 1 of the things that that I will always mention to folks, you know, battling the big c word, right, is
55:15Speaker 4let me say this. In 50 countries around the world, thymosin alpha-one is used in oncology.
55:23Speaker 4So do with that information what you want audience, but do some research on that. I just want you guys to at least be aware of that because that's a big 1. And some of the oncologists, the more forward thinking ones, especially actually in California,
55:35Speaker 4they are starting to incorporate Thymosin Alpha-one in their treatments. That stuff's amazing. I love it. I
55:42Speaker 3forget the name of the actual drug, the pharmaceutical drug that it is, that it's under. But yes, in all these different countries, we did 1, we did peptide
55:51Speaker 3of the week on Thymosin Alpha somewhat recently. Love it. Love it.
55:56Speaker 2Mean- Right on dude. Well, yeah, man, we love you brother. I mean, we could talk forever. Have multiple questions, but we have, we obviously
56:03Speaker 2will have you on. We'd love you to get in here next time. Next time you got my word up, I'll be in there. I'll come down the road. We've done in the studio that we have you on the screen. So as you listeners and people on Spotify and YouTube are watching, we might be looking a little weird in different directions because it was our 1st time we'll get that dialed in because he will not be the 1st that we do this with. We're just used to sitting, talking to each other, but we'll get a hologram. We're going to get a hologram of you sitting
56:29Speaker 3there.
56:30Speaker 2High 5
56:30Speaker 2week.
56:32Speaker 2Get the AI do version of it. That'll work great, man. We love you, man. I love your stuff too. I watch it all the time, man. The Jedi. So tell everybody as we close out, where can they find you? Thank you. You, it's just my name at Paul Bakhtior and Bakhtior is b a k h t I a r across all socials, guys. Thank you so much.
56:53Speaker 3Awesome, man. We're gonna get you, Paul, to respond,
56:58Speaker 3give us some a little bit of input in our elite,
57:01Speaker 3in our, like, warrior elite
57:03Speaker 3new platform, which you don't really know anything about it, but we're going to get you some people who are part of that. We'll get Paul to pop in there every once in a while. Yeah. We will alert people that we do want to talk about that before I forgot.
57:16Speaker 2We have just dropped the Warrior
57:19Speaker 2platform.
57:21Speaker 2We got tired of getting
57:23Speaker 2shadow banned. We got tired of getting things taken down. We got tired of big brother's easiest way to say it. So we built our own platform and we released it 2 days ago and it's exceeded our expectations by a We're blown away by how many people are joining and people are not just joining, they're posting,
57:38Speaker 2they're lifting each other up. They are talking. Oh man, it is just a raddest community.
57:43Speaker 2So join it. We're gonna put the links all over, shoot us DMs, we'll get you in, but get in and you're gonna have access to us, guys like Paul and a lot of other stuff that we can't say on social media, so you wanna do it. So
57:57Speaker 2that is it for the day, my friends, and we will catch you next time.
58:01Speaker 4Thank you, guys.